The cardiovascular health of women is a burgeoning priority in global health, yet postpartum follow-up remains fragmented. This research addresses a critical gap in transition-of-care models by linking obstetric history directly to long-term internal medicine outcomes. As CVD remains the leading cause of mortality in women, identifying high-risk populations through obstetric history allows for early primary prevention. The study provides evidence-based justification for incorporating HDP into standard cardiovascular risk calculators. Furthermore, it highlights the 'Fourth Trimester' as a pivotal phase for health optimization. By establishing the prevalence of subclinical dysfunction within just ten years of delivery, this study advocates for institutional policy changes. It emphasizes the need for multidisciplinary clinics involving obstetricians, cardiologists, and primary care physicians to provide integrated, life-course surveillance for women, potentially reducing the incidence of early-onset heart failure and stroke in the female population.
To quantify the risk of long-term cardiovascular morbidity and structural cardiac remodeling in women with a history of hypertensive disorders of pregnancy compared to those with normotensive gestations over a 10-year follow-up period.
A longitudinal retrospective cohort study was conducted involving 840 women who delivered at a tertiary academic center between 2010 and 2012. Participants were divided into two groups: those with a history of HDP (n=410, including preeclampsia and gestational hypertension) and a control group with normotensive pregnancies (n=430). Data were extracted from electronic health records over a 10-year period. Primary outcomes included the development of chronic hypertension, measured by an average blood pressure ≥140/90 mmHg or initiation of antihypertensive therapy. Secondary outcomes included echocardiographic parameters: Left Ventricular Mass Index (LVMI) and E/e' ratio (diastolic function). Multivariable logistic regression was utilized to calculate Adjusted Odds Ratios (aOR), controlling for age at pregnancy, body mass index (BMI), smoking status, and baseline metabolic profiles. Subgroup analyses were performed for early-onset versus late-onset preeclampsia to determine if the severity of the index event correlated with the magnitude of long-term risk.
At the 10-year follow-up, 38.5% (n=158) of the HDP group had developed chronic hypertension, compared to 12.1% (n=52) in the control group (p
14) was present in 14.6% of women with a history of preeclampsia versus 4.2% in controls (p<0.01). Furthermore, women with early-onset preeclampsia (<34 weeks) exhibited the highest risk profile, with an aOR of 5.12 (95% CI: 3.10–8.45) for cardiovascular events. No significant difference was found in lipid profiles between the groups (p=0.24), suggesting that the increased risk associated with HDP is driven by vascular and pressure-related mechanisms rather than isolated metabolic differences. These data demonstrate a clear, quantifiable link between pregnancy-related hypertension and premature cardiac aging.
Women with a history of HDP exhibit a significantly higher risk of chronic hypertension and adverse cardiac remodeling within a decade of delivery. These findings reinforce that HDP is not merely a transient complication of pregnancy but a marker of permanent vascular and myocardial vulnerability. The significant odds ratios for hypertension and left ventricular hypertrophy suggest that the immediate postpartum period represents a critical window for intervention. Clinical guidelines must transition toward life-course cardiovascular risk assessment for these patients. Implementing mandatory postpartum cardiovascular screening and lifestyle modifications could substantially mitigate the risk of premature heart failure and ischemic heart disease. Future research should focus on whether early therapeutic intervention in the 'fourth trimester' can reverse the subclinical changes observed in this study.